Astrotech Corporation (NASDAQ:ASTC – Get Free Report) was the target of a significant drop in short interest in July. As of July 15th, there was short interest totaling 89,847 shares, a drop of 43.1% from the June 30th total of 157,846 shares. Currently, 6.0% of the shares of the stock are sold short. Based on an average daily volume of 149,729 shares, the short-interest ratio is presently 0.6 days.
Wall Street Analyst Weigh In
Several research firms have commented on ASTC. Wall Street Zen lowered Astrotech from a “sell” rating to a “strong sell” rating in a research note on Monday, July 20th. Weiss Ratings upgraded Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Astrotech has an average rating of “Sell”.
View Our Latest Research Report on ASTC
Astrotech Price Performance
Astrotech (NASDAQ:ASTC – Get Free Report) last posted its earnings results on Wednesday, May 13th. The aerospace company reported ($2.25) EPS for the quarter. The business had revenue of $0.34 million during the quarter. Astrotech had a negative net margin of 1,397.82% and a negative return on equity of 81.85%.
Hedge Funds Weigh In On Astrotech
A number of institutional investors and hedge funds have recently added to or reduced their stakes in ASTC. J. Safra Sarasin Holding AG acquired a new stake in Astrotech during the first quarter worth approximately $140,000. DRW Securities LLC grew its position in shares of Astrotech by 168.5% in the 4th quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock valued at $109,000 after buying an additional 19,747 shares during the last quarter. Finally, Susquehanna International Group LLP purchased a new position in shares of Astrotech in the 3rd quarter valued at $66,000. 24.35% of the stock is owned by institutional investors and hedge funds.
Astrotech Company Profile
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
Recommended Stories
- Five stocks we like better than Astrotech
- McKesson’s Compounding Keeps Adding Up
- Peeling Out or Breaking Down? Ford’s High-Stakes Turnaround
- Generac’s AI Power Story Is Becoming Bigger Than the Weather
- Everyone’s Focused on China—But That’s Not ASML’s Biggest Risk
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
